During the past decade, Washington Center for Pain Management conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Washington Center for Pain Management" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Washington Center for Pain Management" are "Chronic Low Back Pain" (1 trials), "Chronic Nonmalignant and Nonneuropathic Pain" (1 trials), "Degenerative Disc Disease" (1 trials), "Low Back Pain" (1 trials) and "Pain" (1 trials). Many other conditions were trialed in "Washington Center for Pain Management" in a lesser frequency.

Most popular intervention types in "Washington Center for Pain Management" are "Biological" (2 trials), "Device" (2 trials), "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Hydrocodone bitartrate q24h film-coated tablets" (2 trials), "Neurostimulation System" (1 trials), "Placebo to Week 16, tanezumab 10 mg SC" (1 trials), "Placebo to Week 16; tanezumab 5mg SC" (1 trials) and "Placebo to match hydrocodone bitartrate q24h tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "Washington Center for Pain Management" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Washington Center for Pain Management". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Washington Center for Pain Management, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Washington Center for Pain Management, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".